PharmaSGP Holding Investor Relations Material

PharmaSGP Holding SE is a health technology company that specializes in the development, sale, and marketing of non-prescription (over-the-counter) drugs, chemical-free painkillers, and herbal medicines. Established in 2012 and headquartered in Gräefelfing, Germany, the company offers a broad range of healthcare products targeting various medical conditions without the use of chemical substances. Its portfolio includes well-known brands such as Baldriparan, Formigran, Spalt, Kamol, RubaXX, Restaxil, DESEO, and NERADIN, each designed to address specific health concerns like sleep disorders, pain relief, rheumatic pain, and sexual health, among others. Its shares are listed on the XETRA.